CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 06/30/2014

Position Statistics

Total Positions 62
New Positions 16
Increased Positions 25
Decreased Positions 23
Positions with Activity 48
Sold Out Positions 10
Total Mkt Value (in $ millions) 387

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 8.3%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 64.18%
Services
Technology
Transportation
Utilities

48 Activity Positions as of 06/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
RECEPTOS INC COM 24,515 1,475 6.40 478,800
MALLINCKRODT PUB LTD CO SHS 21,582 21,582 New 269,400
CELGENE CORP COM 18,940 18,940 New 200,000
DYAX CORP COM 18,036 -2,004 (10) 1,800,000
OMEROS CORP COM 15,935 8,840 124.60 1,123,000
KARYOPHARM THERAPEUTICS INC COM 13,883 3,786 37.50 385,000
ARROWHEAD RESH CORP COM NEW 12,726 -1,414 (10) 900,000
DEXCOM INC COM 8,856 -4,428 (33.33) 200,000
AKEBIA THERAPEUTICS INC COM 8,740 8,740 New 400,000
SANGAMO BIOSCIENCES INC COM 7,025 -1,405 (16.67) 500,000
NOVAVAX INC COM 6,930 2,310 50 1,500,000
HERON THERAPEUTICS INC COM 6,503 6,503 New 700,000
ULTRAGENYX PHARMACEUTICAL INC COM 6,464 3,232 100 120,000
MERCK & CO INC NEW COM 6,000 -6,000 (50) 100,000
ACCELERON PHARMA INC COM 5,490 5,490 New 200,000
SORRENTO THERAPEUTICS INC COM NEW 5,450 1,635 42.86 1,000,000
CHINA BIOLOGIC PRODS INC COM 5,377 5,377 New 100,000
ACELRX PHARMACEUTICALS INC COM 4,984 -356 (6.67) 700,000
GALECTIN THERAPEUTICS INC COM NEW 4,800 2,712 129.89 800,000
NEUROCRINE BIOSCIENCES INC COM 4,797 4,797 New 300,000